Show simple item record

Linifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Cancer

dc.creatorChen, Jing
dc.creatorGuo, Jiawei
dc.creatorChen, Zhi
dc.creatorWang, Jieqiong
dc.creatorLiu, Mingyao
dc.creatorPang, Xiufeng
dc.date.accessioned2019-10-10T16:47:41Z
dc.date.available2019-10-10T16:47:41Z
dc.date.issued2016
dc.identifier.issn2045-2322
dc.identifier.urihttps://hdl.handle.net/1969.1/182677
dc.format.extent0en
dc.publisherScientific Reports
dc.relation.ispartof1foldr Import 2019-10-08 Batch 9en
dc.relation.uri10.1038/srep29382en
dc.titleLinifanib (ABT-869) Potentiates the Efficacy of Chemotherapeutic Agents through the Suppression of Receptor Tyrosine Kinase-Mediated AKT/mTOR Signaling Pathways in Gastric Canceren


Files in this item

Thumbnail
Name:
document-1.pdf
Size:
1.982Mb
Format:
PDF
View/ Open

This item appears in the following Collection(s)

Show simple item record